Zymeworks ZYME Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$44.16M-7.2% | -$41.21M-110% | -$19.6M-946% | $2.32M+110% | -$22.64M+3.7% | ||
| $963K+7.2% | $898K-0.8% | $905K+2.3% | $885K-9.8% | $981K-1.6% | ||
| $6.94M-21.6% | $8.85M+28.1% | $6.91M+17.7% | $5.87M-8.3% | $6.4M+27.5% | ||
| $2.2M+256% | -$1.41M-929% | $170K+248% | -$115K-128% | $410K+136% | ||
| $26K— | —— | —— | —— | $0— | ||
| $36K+100% | -$24.71M— | —— | -$21.99M+29.6% | -$31.22M-199% | ||
| -$7.75M— | —— | —— | -$7.11M+66.5% | -$21.22M-389% | ||
| $1.73M— | —— | -$3.27M+40.5% | -$5.49M-91.2% | -$2.87M— | ||
| -$340K+56.4% | -$779K-26.9% | -$614K+96.9% | -$19.68M-840% | -$2.09M— | ||
| -$16K+98.3% | -$933K-202% | $915K+3,619% | -$26K-2,500% | -$1K+99.9% | ||
| $176K-4.9% | $185K-71.5% | $648K-59.7% | $1.61M-0.7% | $1.62M-19.2% | ||
| $1.71M+84.8% | $924K-10.4% | $1.03M+42.6% | $723K+2.3% | $707K+2.5% | ||
| -$45.72M-346% | -$10.26M+67.3% | -$31.41M-360% | $12.07M+454% | -$3.41M+91.8% | ||
| $216K-62.8% | $581K+41.7% | $410K-20.2% | $514K+3,113% | $16K-94.9% | ||
| $0-100% | $139K— | $0-100% | $370K+14.9% | $322K— | ||
| $69.96M+1,203% | $5.37M+1,359% | $368K-95.8% | $8.75M-28.2% | $12.18M— | ||
| $76.15M+199% | $25.48M— | —— | —— | $0-100% | ||
| $8.72M+186% | -$10.08M-227% | $7.92M+472% | $1.38M+79.3% | $772K— | ||
| $178.79M+1,054% | -$18.74M-664% | -$2.45M-286% | $1.32M+0.2% | $1.32M+115% | ||
| $98K+323% | -$44K— | —— | -$88K-980% | $10K-91.2% | ||
| $203.13M+958% | -$23.68M+29.2% | -$33.42M-252% | $22.05M+118% | $10.1M+118% | ||
| $245K+129% | $107K-83.8% | $660K+237% | $196K-49.4% | $387K-87.0% | ||
| $26K— | —— | —— | —— | $0— | ||
| $176K-4.9% | $185K-71.5% | $648K-59.7% | $1.61M-0.7% | $1.62M-19.2% | ||
| $963K+7.2% | $898K-0.8% | $905K+2.3% | $885K-9.8% | $981K-1.6% | ||
| $331K+209% | -$305K— | —— | -$710K-2,319% | $32K-96.4% | ||
| $2.2M+256% | -$1.41M-929% | $170K+248% | -$115K-128% | $410K+136% | ||
| -$1.01M-19.9% | -$838K+3.9% | -$872K-6.6% | -$818K-0.5% | -$814K-4.1% | ||
| $1.73M— | —— | -$3.27M+40.5% | -$5.49M-91.2% | -$2.87M— | ||
| $2.04M— | —— | —— | —— | $0— | ||
| $1.71M+84.8% | $924K-10.4% | $1.03M+42.6% | $723K+2.3% | $707K+2.5% | ||
| $0-100% | $139K— | $0-100% | $370K+14.9% | $322K— | ||
| $4.39M— | —— | —— | —— | $0— | ||
| $607K— | —— | $881K— | —— | $544K— | ||
| $8.72M+27.7% | $6.83M-13.9% | $7.92M+472% | $1.38M+79.3% | $772K-1.7% | ||
| $250M— | —— | —— | —— | $0— | ||
| $0— | $0-100% | $1.42M+448% | $259K-66.1% | $765K— | ||
| $245K+129% | $107K-83.8% | $660K+237% | $196K-49.4% | $387K-87.0% | ||
| -$45.93M-324% | -$10.84M+65.9% | -$31.82M-375% | $11.56M+438% | -$3.42M+91.8% | ||
| -$45.93M-324% | -$10.84M+65.9% | -$31.82M-375% | $11.56M+438% | -$3.42M+91.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Zymeworks generate?
- Zymeworks (ZYME) generated -$75.3M in operating cash flow over the trailing twelve months.
- What is Zymeworks's free cash flow?
- After $1.7M of capital expenditures, Zymeworks's free cash flow was -$77.0M over the trailing twelve months, up 0.7% year over year.
- Where does Zymeworks's cash flow data come from?
- Every line is extracted from Zymeworks's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
